MedTrace Logo

Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS

NCT03673995 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 186

Last updated 2020-06-16

No results posted yet for this study

Summary

PCOS patients were treated every day, with one sachet containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid. All patients underwent, before starting the therapy, after 3 months and 6 months, hormonal evaluation , hirsutism scoring and ovulation assesment. Most of them during the treatment improved their symptoms.

Conditions

  • Polycystic Ovary Syndrome
  • Menstrual Problem
  • Hirsutism

Interventions

DIETARY_SUPPLEMENT

Myo-inositol+L-tyrosine

PCOS patients were treated every day, with one sachet containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid. All patients underwent, before starting the therapy, after 3 months and 6 months, hormonal, hirsutism and ovulation assesment.

Sponsors & Collaborators

  • Pharmarte srl

    lead INDUSTRY

Principal Investigators

  • Mario Montanino Oliva, M.D. · Altamedica Reproductive Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-02
Primary Completion
2018-08-22
Completion
2018-10-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03673995 on ClinicalTrials.gov